CoviTeD
Cohort C
A high impact program for accelerated deployment with regulatory & funding support.
AIC-CCMB has initiated
several activities including support for development and validation of novel
Covid-19 innovations by start-ups and MSMEs. Our goal is to support and rapidly
deploy diagnostics and therapeutics through the participation of research
institutes, industries, policy maker and incubators.
AIC-CCMB is inviting
entrepreneurs and innovators with promising technologies to join our Covid-19
Technology Deployment (CoviTeD) Acceleration Program. A CSR initiative of
Security Printing and Minting Corporation of India Limited (SPMCIL), the
CoviTeD program aim to provide high impact mentoring, financial,
regulatory and marketing support to take the products and technologies of
startups to market. The selected startup for CoviTeD Acceleration Program will be funded up-to 10-15 Lakhs after evaluation.
Applications invited
from start-ups in the areas of:
·
Rapid Diagnostics
·
Drugs & Therapeutics
·
Medical devices
·
Quantifiable tests for ancillary markers
of Covid-19
·
Sterilization and hygiene
·
Infectious Disease
·
Mobility Solutions
·
Remote Monitoring
·
Logistics for biologicals
All the
proposals shall be considered by a Management Committee (MC) constituted by
AIC-CCMB. Only the proposals approved by the MC shall be allowed access to
the facility and undertake project work on the agreed terms and conditions for development
of innovative products and processes.